BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5597847)

  • 41. [Characteristics of Vi-antibody formation in typhoid fever and chronic typhoid fever bacterial carriers].
    Karmanov MI
    Sov Med; 1973 May; 36(5):149-50. PubMed ID: 4768336
    [No Abstract]   [Full Text] [Related]  

  • 42. [CHANGES IN ANTIBACTERIAL IMMUNITY TO TYPHOID UNDER THE INFLUENCE OF DYSENTERY INFECTION AND INFLUENZA].
    PINEGIN BV
    Zh Mikrobiol Epidemiol Immunobiol; 1963 Aug; 40():29-34. PubMed ID: 14091794
    [No Abstract]   [Full Text] [Related]  

  • 43. [Immunochemical characteristics of typhoid O-antibodies in people and experimental animals according to radioimmunoelectrophoretic findings].
    Chernokhvostova EV; Anokhin VL; Zheverzheeva VF
    Zh Mikrobiol Epidemiol Immunobiol; 1967 Jun; 44(6):15-7. PubMed ID: 5616822
    [No Abstract]   [Full Text] [Related]  

  • 44. QUANTITATIVE STUDIES OF FEBRILE TOLERANCE AND LEVELS OF SPECIFIC ANTIBODY EVOKED BY BACTERIAL ENDOTOXIN.
    MULHOLLAND JH; WOLFF SM; JACKSON AL; LANDY M
    J Clin Invest; 1965 Jun; 44(6):920-8. PubMed ID: 14322026
    [No Abstract]   [Full Text] [Related]  

  • 45. An Unmutated IgM Response to the Vi Polysaccharide of
    Pandya KD; Palomo-Caturla I; Walker JA; K Sandilya V; Zhong Z; Alugupalli KR
    J Immunol; 2018 Jun; 200(12):4078-4084. PubMed ID: 29743315
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preparation of an artificial antigen and immunity to mouse typhoid.
    Jenkin CR; Karnovsky ML; Rowley D
    Immunology; 1967 Oct; 13(4):361-72. PubMed ID: 4861746
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential agglutination of particulate Vi and O antigens by the IgM and IgG class antibodies.
    Chau PY; Ng MH
    Aust J Exp Biol Med Sci; 1978 Feb; 56(1):39-45. PubMed ID: 666676
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Research on distribution of O and H agglutinins in immunoglobulins of typhoid patients].
    Ricci G; Turbessi G; Aiuti F; De Bac C
    Minerva Med; 1965 Dec; 56(99):4343-8. PubMed ID: 5858469
    [No Abstract]   [Full Text] [Related]  

  • 49. Vaccination Method Affects Immune Response and Bacterial Growth but Not Protection in the Salmonella Typhimurium Animal Model of Typhoid.
    Kinnear CL; Strugnell RA
    PLoS One; 2015; 10(10):e0141356. PubMed ID: 26509599
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Material on the characteristics of the active immunity test in the evaluation of the immunogenicity of typhoid-paratyphoid vaccines in experiments on white mice].
    Rumiantsev SN; Karpenkova NI; Chalenko VG
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Feb; 49(2):9-15. PubMed ID: 4623777
    [No Abstract]   [Full Text] [Related]  

  • 51. Typhoid gamma G, gamma M and gamma A antibodies in persons with different relation to the typhoid infection.
    Ciznár I; Farbakyová G; Draskovicová M; Karolcek J
    Zentralbl Bakteriol Orig A; 1975; 231(1-3):108-15. PubMed ID: 808046
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Two types of immunity in experimental typhoid; "cellular immunity" and "humoral immunity".
    Ushiba D
    Keio J Med; 1965 Jun; 14(2):45-61. PubMed ID: 5827250
    [No Abstract]   [Full Text] [Related]  

  • 53. Plasma Immunoglobulin A Responses Against 2 Salmonella Typhi Antigens Identify Patients With Typhoid Fever.
    Andrews JR; Khanam F; Rahman N; Hossain M; Bogoch II; Vaidya K; Kelly M; Calderwood SB; Bhuiyan TR; Ryan ET; Qadri F; Charles RC
    Clin Infect Dis; 2019 Mar; 68(6):949-955. PubMed ID: 30020426
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies on infection and immunity in experimental typhoid fever. 8. Intravenous and intra-lymph node challenge of chimpanzees with Salmonella typhi.
    Gaines S; Tully JG; Tigertt WD
    J Infect Dis; 1968 Oct; 118(4):393-401. PubMed ID: 4880691
    [No Abstract]   [Full Text] [Related]  

  • 55. [Production of a complex chemical typhoid vaccine containing O-, Vi, and H-antigens].
    Gekker VD; Sergeeva NS
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Jan; 50(1):14-8. PubMed ID: 4780106
    [No Abstract]   [Full Text] [Related]  

  • 56. The unmasking of typhoid fever.
    Woodward TE
    S Afr Med J; 1970 Jan; 44(5):99-106. PubMed ID: 5415784
    [No Abstract]   [Full Text] [Related]  

  • 57. Competition of 19S and 7S antigen receptors in the regulation of the primary immune response.
    Henry C; Jerne NK
    J Exp Med; 1968 Jul; 128(1):133-52. PubMed ID: 5662011
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunization against typhoid fever.
    Warren JW; Hornick RB
    Annu Rev Med; 1979; 30():457-72. PubMed ID: 400506
    [No Abstract]   [Full Text] [Related]  

  • 59. M-01ZH09, an oral live attenuated Salmonella enterica serovar Typhi vaccine for the prevention of typhoid fever.
    Jain SK
    Curr Opin Mol Ther; 2009 Oct; 11(5):565-71. PubMed ID: 19806505
    [TBL] [Abstract][Full Text] [Related]  

  • 60. THE BASIS FOR IMMUNITY TO MOUSE TYPHOID. 2. ANTIBODY FORMATION DURING THE CARRIER STATE.
    TURNER KJ; JENKIN CR; ROWLEY D
    Aust J Exp Biol Med Sci; 1964 Apr; 42():229-36. PubMed ID: 14150757
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.